Oxford BioMedica (OTCMKTS:OXBDF) Sets New 1-Year High - Here's What Happened

Key Points

• Oxford BioMedica's shares reached a new 52-week high of $6.72 during trading on Friday, reflecting a significant increase from the previous close of $6.26.
• The company specializes in advanced gene delivery systems through its LentiVector platform, aiming to address safety and delivery challenges in therapeutics.
• The stock has demonstrated strong price performance, with a 50-day moving average of $5.02 and a 200-day moving average of $4.43.

Shares of Oxford BioMedica (OTCMKTS:OXBDF - ) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $6.72 and last traded at $6.72, with a volume of 520 shares traded. The stock had previously closed at $6.26.

Oxford BioMedica Price Performance

The business's 50-day moving average price is $5.02 and its two-hundred day moving average price is $4.43.

Oxford BioMedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.